Literature DB >> 12218343

Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.

Maria Paz Marco, Salomé Muray, Angels Betriu, Lourdes Craver, Montserrat Belart, Elvira Fernández.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218343     DOI: 10.1159/000063307

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

1.  Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients.

Authors:  Vikas R Dharnidharka; Stanton K Wesson; Robert S Fennell
Journal:  Pediatr Nephrol       Date:  2006-12-16       Impact factor: 3.714

2.  Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.

Authors:  Ashima Gulati; Vijesh Sridhar; Tathagata Bose; Pankaj Hari; Arvind Bagga
Journal:  Int Urol Nephrol       Date:  2009-12-18       Impact factor: 2.370

3.  Nephrogenic fibrosing dermopathy in pediatric patients.

Authors:  Sima M Jain; Stanton Wesson; Ashraf Hassanein; Erica Canova; Miranda Hoy; Robert S Fennell; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2004-02-10       Impact factor: 3.714

4.  Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.

Authors:  Veerle P Persy; Geert J Behets; Marc E De Broe; Patrick C D'Haese
Journal:  Int J Nephrol Renovasc Dis       Date:  2009-04-01

Review 5.  Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients.

Authors:  Shahrzad Ossareh
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-05-08

Review 6.  The pathophysiology of leg cramping during dialysis and the use of carnitine in its treatment.

Authors:  Akira Takahashi
Journal:  Physiol Rep       Date:  2021-11

Review 7.  Update and critical appraisal of sevelamer in the management of chronic renal failure.

Authors:  Jacob Grinfeld; Akimichi Inaba; Alastair J Hutchison
Journal:  Open Access J Urol       Date:  2010-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.